Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
31
|
pubmed:dateCreated |
1972-7-17
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0026-4806
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1786-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:5025176-Antineoplastic Agents,
pubmed-meshheading:5025176-Carcinogens,
pubmed-meshheading:5025176-Carcinoma,
pubmed-meshheading:5025176-Humans,
pubmed-meshheading:5025176-Immunosuppression,
pubmed-meshheading:5025176-Leukemia,
pubmed-meshheading:5025176-Neoplasms,
pubmed-meshheading:5025176-Sarcoma
|
pubmed:year |
1972
|
pubmed:articleTitle |
[Problem of the cancerogenicity of cytostatics].
|
pubmed:publicationType |
Journal Article
|